Universal American: A Healthy Collaboration

Universal American Home
Investor Relations
Stock Quote & Chart
Press Releases
Financial Reports
Quarterly Results
Annual
Meeting/Proxy
Calendar
SEC Filings
Analyst Coverage
Presentations
Audio Archives
Tax Implications of
2016 Dividend
Tax Implications of
2015 Dividend
Tax Implications of
2014 Dividend
Tax Implications of
2013 Dividend
Tax Implications of
2012 Dividend
Tax Implications –
Part D Sale
E-mail Alerts
Request Info

Print PagePrint Page
E-mail PageE-mail Page
RSS FeedsRSS Feeds
IR ContactsIR Contacts

SEC Filings

Form 10-K
UNIVERSAL AMERICAN CORP. filed this Form 10-K on 02/28/2017
Document Outline
Entire Document (13166.2 KB)
Subdocument 1 - 10-K - 10-K
Page 1 - UNITED STATES
Page 2 - TABLE OF CONTENTS
Page 3 - DISCLOSURE REGARDING FORWARD LOOKING STATEMENTS
Page 4 - PART I
Page 5 - Our Operating Segments
Page 6 - Medicare Advantage Texas:
Page 7 - Accountable Care Organizations
Page 8 - Regulation Accountable Care Organizations
Page 9 - Competition
Page 10 - Investments
Page 11 - Reserves
Page 12 - Medicare
Page 13 - Stipulated minimum MLRs
Page 14 - Fraud and abuse laws
Page 15 - Privacy laws
Page 16 - Dividend Restrictions
Page 17 - Risk-Based Capital and Minimum Capital Requirements
Page 18 - Pharmacy Benefit Management
Page 19 - ITEM 1A RISK FACTORS
Page 20 - The Merger Agreement prohibits us from pursuing alternative transactions to the Merger.
Page 21 - Reduced Medicare Advantage reimbursement rates
Page 22 - Implementation of quality bonus for Star Ratings
Page 23 - N/A
Page 24 - Stipulated Minimum MLRs
Page 25 - We are subject to extensive government regulation; compliance with laws and regulations is complex a
Page 26 - N/A
Page 27 - If we fail to effectively design and price our products properly and competitively, if the premiums
Page 28 - Reductions in funding for Medicare programs could materially reduce our ability to achieve profitabi
Page 29 - Competition in the healthcare industry is intense, and if we do not design and price our products pr
Page 30 - Changes in governmental regulation or legislative reform could increase our costs of doing business
Page 31 - If we fail to properly maintain the integrity of our data and information systems and we sustain a c
Page 32 - N/A
Page 33 - CMS's risk adjustment payment system, including the manner in which we estimate CMS revenues and the
Page 34 - N/A
Page 35 - Accounting Changes.
Page 36 - Because our Medicare Advantage premiums, which generate most of our Medicare Advantage revenues, are
Page 37 - We hold reserves for expected claims, which are estimated, and these estimates involve an extensive
Page 38 - Legal and regulatory investigations and actions are increasingly common in the managed care business
Page 39 - N/A
Page 40 - We rely on the accuracy of information provided by CMS regarding the eligibility of an individual to
Page 41 - If we are unable to develop and maintain satisfactory relationships with the providers of care to ou
Page 42 - A reduction in the number of members in our Medicare Advantage plans could adversely affect our resu
Page 43 - Our Medicare Advantage membership remains concentrated in certain geographic areas, which exposes us
Page 44 - The occurrence of natural or man-made disasters could adversely affect our financial condition and r
Page 45 - N/A
Page 46 - Our reliance upon third party administrators and other outsourcing arrangements may disrupt or adver
Page 47 - We may be responsible for the actions of our third party agents, and restrictions on our ability to
Page 48 - We may not have adequate intellectual property rights in our brand names for our health plans, and w
Page 49 - Our ability to obtain funds from our regulated subsidiaries is restricted and our cash flows and liq
Page 50 - Our stock price may be volatile and could drop precipitously and unexpectedly.
Page 51 - Some of our shareholders, directors and executive officers may have interests that conflict with, ar
Page 52 - Future sales of our common stock in the public market could lower the market price for our common st
Page 53 - Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow f
Page 54 - ITEM 1B UNRESOLVED STAFF COMMENTS
Page 55 - ITEM 4 MINE SAFETY DISCLOSURES
Page 56 - PART II
Page 57 - Comparison of Cumulative Total Return Among
Page 58 - N/A
Page 59 - N/A
Page 60 - ITEM 7 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Page 61 - Healthy Collaboration Strategy
Page 62 - Medicare Advantage Northeast:
Page 63 - MSSP Track 1:
Page 64 - N/A
Page 65 - Healthcare Reform
Page 66 - Implementation of quality bonus for Star ratings
Page 67 - Non-deductible health insurance industry fee ("ACA Fee")
Page 68 - Special Cash Dividend
Page 69 - Membership
Page 70 - Results of Operations Consolidated Overview
Page 71 - Years ended December 31, 2015 and 2014
Page 72 - N/A
Page 73 - Segment Results Medicare Advantage
Page 74 - ACA fee.
Page 75 - Net premiums.
Page 76 - Segment Results Management Services Organization
Page 77 - Years ended December 31, 2016 and 2015
Page 78 - Segment Results Corporate Other
Page 79 - Commissions and general expenses.
Page 80 - Discontinued Operations
Page 81 - APS Healthcare:
Page 82 - Contractual Obligations and Commercial Commitments
Page 83 - N/A
Page 84 - Sources and Uses of Liquidity of Our Subsidiaries
Page 85 - Medicare Advantage Management Service Organizations.
Page 86 - Critical Accounting Policies
Page 87 - N/A
Page 88 - Sensitivity Analysis
Page 89 - Goodwill and intangible assets
Page 90 - N/A
Page 91 - Valuation of acquired intangible assets.
Page 92 - N/A
Page 93 - Medicare Overview
Page 94 - Part C
Page 95 - Revenue Adjustments
Page 96 - Catastrophic Reinsurance
Page 97 - Income Taxes
Page 98 - Federal Income Taxation of the Company
Page 99 - ITEM 8 FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Page 100 - Evaluation of Effectiveness of Controls
Page 101 - PART III
Page 102 - PART IV
Page 103 - N/A
Page 104 - N/A
Page 105 - SIGNATURES
Page 106 - UNIVERSAL AMERICAN CORP. AND SUBSIDIARIES
Page 107 - Report of Independent Registered Public Accounting Firm
Page 108 - Internal Control Integrated Framework (2013)
Page 109 - Report of Independent Registered Public Accounting Firm
Page 110 - Report of Independent Registered Public Accounting Firm
Page 111 - N/A
Page 112 - CONSOLIDATED BALANCE SHEETS
Page 113 - CONSOLIDATED STATEMENTS OF OPERATIONS
Page 114 - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Page 115 - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
Page 116 - CONSOLIDATED STATEMENTS OF CASH FLOWS
Page 117 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Page 118 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 119 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 120 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 121 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 122 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 123 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 124 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 125 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 126 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 127 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 128 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 129 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 130 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 131 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 132 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 133 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 134 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 135 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 136 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 137 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 138 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 139 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 140 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 141 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 142 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 143 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 144 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 145 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 146 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 147 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 148 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 149 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 150 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 151 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 152 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 153 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 154 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 155 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 156 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 157 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 158 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 159 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 160 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 161 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 162 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 163 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 164 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 165 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 166 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 167 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 168 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 169 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 170 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 171 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 172 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Page 173 - Schedule I Summary of Investments Other Than Investments in Related Parties
Page 174 - Schedule II Condensed Financial Information of Registrant
Page 175 - N/A
Page 176 - N/A
Page 177 - 1. BASIS OF PRESENTATION
Page 178 - NOTES TO CONDENSED FINANCIAL STATEMENTS (Continued)
Page 179 - NOTES TO CONDENSED FINANCIAL STATEMENTS (Continued)
Page 180 - NOTES TO CONDENSED FINANCIAL STATEMENTS (Continued)
Page 181 - Schedule III SUPPLEMENTAL INSURANCE INFORMATION
Page 182 - Universal American Corp.
Subdocument 2 - EX-12.1 - EX-12.1
Page 1 - Exhibit 12.1
Page 2 - N/A
Subdocument 3 - EX-21.1 - EX-21.1
Page 1 - Exhibit 21.1
Page 2 - N/A
Page 3 - N/A
Subdocument 4 - EX-23.1 - EX-23.1
Page 1 - Exhibit 23.1
Page 2 - N/A
Subdocument 5 - EX-23.2 - EX-23.2
Page 1 - Exhibit 23.2
Page 2 - N/A
Subdocument 6 - EX-31.1 - EX-31.1
Page 1 - Exhibit 31.1
Page 2 - N/A
Subdocument 7 - EX-31.2 - EX-31.2
Page 1 - Exhibit 31.2
Page 2 - N/A
Subdocument 8 - EX-31.3 - EX-31.3
Page 1 - Exhibit 31.3
Page 2 - N/A
Subdocument 9 - EX-32.1 - EX-32.1
Page 1 - Exhibit 32.1
Page 2 - N/A
XBRL Item - EX-101.INS - EX-101.INS (What's this?)
XBRL Item - EX-101.SCH - EX-101.SCH (What's this?)
XBRL Item - EX-101.CAL - EX-101.CAL (What's this?)
XBRL Item - EX-101.DEF - EX-101.DEF (What's this?)
XBRL Item - EX-101.LAB - EX-101.LAB (What's this?)
XBRL Item - EX-101.PRE - EX-101.PRE (What's this?)
XBRL Viewer



© 2002-2008 Universal American